Prudential Financial’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.04M	Buy	256,545 +21,630	+9%	+$552K	0.01%	843
2025 Q4	$6.82M	Buy	234,915 +220,980	+1,586%	+$5.66M	0.01%	786
2025 Q3	$263K	Sell	13,935 -584,965	-98%	-$9.23M	﹤0.01%	2136
2025 Q2	$8.4M	Buy	598,900 +5,705	+1%	+$80K	0.01%	703
2025 Q1	$9.28M	Buy	593,195 +630	+0.1%	+$8.88K	0.01%	612
2024 Q4	$8.25M	Buy	592,565 +19,950	+3%	+$219K	0.01%	686
2024 Q3	$5.33M	Hold	572,615	–	–	0.01%	970
2024 Q2	$5.33M	Sell	572,615 -150,710	-21%	-$1.36M	0.01%	895
2024 Q1	$7.17M	Sell	723,325 -94,730	-12%	-$707K	0.01%	784
2023 Q4	$2.64M	Buy	818,055 +454,640	+125%	+$1.24M	﹤0.01%	1266
2023 Q3	$2.01M	Hold	363,415	–	–	﹤0.01%	1364
2023 Q2	$3.46M	Buy	363,415 +200,585	+123%	+$2.23M	0.01%	1095
2023 Q1	$1.79M	Buy	162,830 +65,975	+68%	+$954K	﹤0.01%	1409
2022 Q4	$1.43M	Buy	96,855 +30,020	+45%	+$524K	﹤0.01%	1510
2022 Q3	$1.28M	Buy	66,835 +340	+0.5%	+$7.7K	﹤0.01%	1619
2022 Q2	$1.42M	Buy	+66,495	New	+$1.36M	﹤0.01%	1592